|
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal Clinical research trials and Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal. Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal clinical trial. Test subjects typically receive the most effective healthcare possible for their Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal  Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
For Condition: Alcoholism
Status: Recruiting
Sponsor(s): National Institute on Alcohol Abuse and Alcoholism (NIAAA) ,
Synopsis: This study will evaluate a safe and useful medication for outpatient detoxification that is as effective as benzodiazepines in the short-term, and more effective in the protracted withdrawal period. Gabapentin (Neurontin) will be compared to a standard benzodiazepine, lorazepam (Ativan), for its effectiveness in treating alcohol withdrawal.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - Meets criteria for alcohol dependence and uncomplicated alcohol withdrawal syndrome. - Subjects must be medically stable (not likely to require hospitalization for medical complications within 10 days). - Have a clinical withdrawal assessment prior to study. - Must be medically acceptable for study treatment. Considerations include no past or present physical disorder that is likely to deteriorate during participation. No ECG abnormality which would likely worsen during participation and no clinical laboratory abnormality that would also suggest deterioration during treatment. - Able to read, write, and speak English. - Have a negative urine drug screen for benzodiazepines or other sedative hypnotics, opiates, and stimulates prior to entering the study. Exclusion Criteria: - Current diagnosis of any other substance dependence syndrome other than alcohol dependence (excluding nicotine and caffeine dependence). - Use of pharmacological agents within the last 14 days that are known to lower the seizure threshold or augment or decrease the alcohol withdrawal syndrome. - History of alcohol withdrawal seizures, epilepsy or delirium tremens. - Diagnosis of schizophrenia, bipolar disorder or dementia. - Liver function tests higher than normal. - History of hepatic encephalopathy, jaundice, ascites, diabetes, or renal disease. - Females who are pregnant or nursing. - Subjects with known sensitivity of previous adverse reaction to gabapentin, lorazepam, or other benzodiazepines. - History of severe GI disease which might render absorption of the medication difficult or produce medical instability of the patient during detoxification which would include active peptic ulcer disease, ulcerative colitis, regional colitis, or evidence by history or physical exam of GI bleeding. - Unable to provide an informed consent.
Total Enrollment: 160
Location and Contact Information:
Medical University of South Carolina *Recruiting*
Charleston, South Carolina, 29425
United States
Recruiting Dr. Malcolm 843-792-5214
Additional Information:
Study ID Numbers: NIAAAMAL1076106;
Study Start Date:
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00011297
Other Alcoholism Studies:
1. Pharmacologic Relapse Prevention for Alcoholic Smokers
2. Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)
3. Ondansetron Treatment for Alcoholism
4. Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens
5. Improving Substance Abuse Treatment Aftercare Adherence and Outcome
Related Studies:
Other Alcoholism Clinical Trials
Other South Carolina Clinical Trials
Other Charleston Clinical Trials
Comparing Gabapentin and Lorazepam for Treating Alcohol Withdrawal
|
|
|
|
|
|
|
|
